Filing Details
- Accession Number:
- 0001093557-21-000195
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-04 20:36:10
- Reporting Period:
- 2021-08-03
- Accepted Time:
- 2021-08-04 20:36:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1323190 | K Andrew Balo | 6340 Sequence Drive San Diego CA 92121 | * | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-03 | 683 | $512.19 | 12,726 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2021-08-03 | 200 | $512.83 | 12,526 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2021-08-03 | 300 | $514.18 | 12,226 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2021-08-03 | 300 | $515.33 | 11,926 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2021-08-03 | 200 | $516.72 | 11,726 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2021-08-03 | 200 | $518.06 | 11,526 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2021-08-03 | 525 | $519.24 | 11,001 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2021-08-03 | 349 | $519.92 | 10,652 | No | 4 | S | Indirect | by Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 16,533 | Direct |
Footnotes
- On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- This transaction was executed in multiple trades at prices ranging from $511.45 to $512.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee.
- This transaction was executed in multiple trades at prices ranging from $512.46 to $513.39. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $513.59 to $514.43. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $515.00 to $515.92. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $516.425 to $517.020. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $517.600 to $518.515. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $518.60 to $519.50. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $519.64 to $520.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
